Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$970M |
| 2 |
AbbVie
ABBV
|
+$554M |
| 3 |
IBM
IBM
|
+$535M |
| 4 |
TC Energy
TRP
|
+$489M |
| 5 |
McKesson
MCK
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.32B |
| 2 |
MON
Monsanto Co
MON
|
+$1.1B |
| 3 |
Kinder Morgan
KMI
|
+$684M |
| 4 |
Amgen
AMGN
|
+$670M |
| 5 |
Danaher
DHR
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.92% |
| 2 | Technology | 12.36% |
| 3 | Communication Services | 10.31% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Energy | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Autodesk
ADSK
$52.2B
| $328M | 0.11% |
4,530,005
| – | – |
|
177
Perrigo
PRGO
$1.78B
| $324M | 0.11% |
3,511,360
-5,019,333
| -59% | -$463M |
|
178
Abbott
ABT
$193B
| $318M | 0.11% |
7,511,583
-1,497
| -0% | -$64.1K |
|
179
Melco Resorts & Entertainment
MLCO
$2.16B
| $318M | 0.11% |
19,714,059
+6,575
| +0% | +$92.5K |
|
180
Kimberly-Clark
KMB
$36.6B
| $315M | 0.1% |
2,500,000
| – | – |
|
181
Wells Fargo
WFC
$267B
| $309M | 0.1% |
6,973,379
+299,354
| +4% | +$14.3M |
|
|
MON
182
DELISTED
Monsanto Co
MON
| $302M | 0.1% |
2,955,018
-10,469,265
| -78% | -$1.1B |
|
|
AVP
183
DELISTED
Avon Products, Inc.
AVP
| $302M | 0.1% |
53,353,416
-7,392
| -0% | -$36.9K |
|
|
TMX
184
DELISTED
Terminix Global Holdings, Inc.
TMX
| $297M | 0.1% |
13,184,683
+955,520
| +8% | +$24M |
|
185
AutoNation
AN
$6.89B
| $292M | 0.1% |
6,000,000
| – | – |
|
|
IOC
186
DELISTED
Interoil Corporation
IOC
| $282M | 0.09% |
5,535,729
+6,114
| +0.1% | +$300K |
|
187
SM Energy
SM
$7.6B
| $280M | 0.09% |
7,245,940
+37,000
| +0.5% | +$1.19M |
|
188
Domino's
DPZ
$11.6B
| $273M | 0.09% |
1,795,300
| – | – |
|
|
BLUE
189
DELISTED
bluebird bio
BLUE
| $271M | 0.09% |
308,245
-40,980
| -12% | -$29.7M |
|
190
Lumentum
LITE
$83.7B
| $269M | 0.09% |
6,443,070
+1,616
| +0% | +$53.2K |
|
191
Alexandria Real Estate Equities
ARE
$8.32B
| $266M | 0.09% |
2,442,904
-413,000
| -14% | -$45M |
|
192
AptarGroup
ATR
$8.43B
| $261M | 0.09% |
3,370,003
| – | – |
|
193
Capital One
COF
$136B
| $259M | 0.09% |
3,609,670
-431
| -0% | -$29.6K |
|
194
Healthpeak Properties
DOC
$14.3B
| $259M | 0.09% |
7,488,360
| – | – |
|
195
Ralph Lauren
RL
$23.1B
| $258M | 0.09% |
2,550,003
| – | – |
|
|
WFM
196
DELISTED
Whole Foods Market Inc
WFM
| $258M | 0.09% |
9,091,437
-1,053
| -0% | -$32.4K |
|
197
Williams-Sonoma
WSM
$29B
| $257M | 0.08% |
10,052,012
| – | – |
|
198
Boston Scientific
BSX
$74.8B
| $252M | 0.08% |
10,570,002
| – | – |
|
199
Public Storage
PSA
$60.9B
| $251M | 0.08% |
1,126,000
| – | – |
|
200
Truist Financial
TFC
$64.7B
| $250M | 0.08% |
6,615,000
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2016 Portfolio in Review
As of Q3 2016, Capital Research Global Investors held 443 positions worth $303B, up 3.4% from $292B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q3 2016 filing shows 24 new, 126 increased, 140 reduced and 30 closed positions. Its largest new stake was TC Energy: 10,475,000 shares worth $498M. The largest sale was Alexion Pharmaceuticals, an estimated $1.32B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q3 2016 buy was TC Energy: 10,475,000 shares worth $498M.
- Capital Research Global Investors added most to ExxonMobil in Q3 2016, an estimated $970M increase.
- Capital Research Global Investors's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.32B.
- Capital Research Global Investors fully exited Waste Management in Q3 2016, selling an estimated $637M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $303B portfolio in Q3 2016.
- Capital Research Global Investors opened 24 new positions and closed 30 in Q3 2016.
- Capital Research Global Investors's portfolio value rose 3.4% quarter-over-quarter to $303B.
Based on Capital Research Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.